Page last updated: 2024-08-24

lercanidipine and Goldblatt Syndrome

lercanidipine has been researched along with Goldblatt Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bendhack, LM; Castro, MM; Demacq, C; Fernandes, K; Gerlach, RF; Martinez, ML; Rizzi, E; Tanus-Santos, JE	1

Other Studies

1 other study(ies) available for lercanidipine and Goldblatt Syndrome

Article	Year
Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats. European journal of pharmacology, 2008, Sep-04, Volume: 591, Issue:1-3 Topics: Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Disease Models, Animal; Enzyme Precursors; Gelatinases; Hypertension, Renovascular; Male; Matrix Metalloproteinase 2; Oxidative Stress; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; Thiobarbituric Acid Reactive Substances; Vasodilation	2008

Article

Year

Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats.

European journal of pharmacology, 2008, Sep-04, Volume: 591, Issue:1-3

Topics: Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Disease Models, Animal; Enzyme Precursors; Gelatinases; Hypertension, Renovascular; Male; Matrix Metalloproteinase 2; Oxidative Stress; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; Thiobarbituric Acid Reactive Substances; Vasodilation

2008